Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
Na/c18-16-19-20-17(24-9-15(22)23)21(16)14-8-7-11(10-5-6-10)12-3-1-2-4-13(12)14
which does not allow the beta-lactamases to bind
Tioguanine (INN
CN1C2NC=NC=2C(=O)N(C)C1=O
Preclinical studies reveal that KW-2449 is converted by monoamine oxidase-B (MAO-B) and aldehyde oxidase into its major metabolite M1
Vortioxetine hydrobromide troban Na/c18-16-19-20-17(24-9-15(22)23)21(16)14-8-7-11(10-5-6-10)12-3-1-2-4-13(12)14Vortioxetine, also known as Lu AA21004, is an atypical antidepressant, and was approved in 2013 by the U. S. FDA for the treatment of major depressive disorder (MDD) in adults. Vortioxetine is a so called "serotonin modulator and stimulator." It has been shown to possess the following pharmacological actions: Serotonin transporter (SERT) blocker (i. e. serotonin reuptake inhibitor (SRI)) Ki (binding affinity) = 1. 6 nM, IC50 = 5. 4 nM; Norepinephrine
US$ 188.00
US$ 13.95
US$ 1926.00
US$ 15.84
US$ 194.88
US$ 36.95
US$ 19.95
US$ 1277.38
US$ 11.00